476 related articles for article (PubMed ID: 23172872)
21. Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer.
Stine ZE; McGaughey DM; Bessling SL; Li S; McCallion AS
Hum Mol Genet; 2011 Oct; 20(19):3746-56. PubMed ID: 21737465
[TBL] [Abstract][Full Text] [Related]
22. Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer.
Jacquemier J; Charafe-Jauffret E; Monville F; Esterni B; Extra JM; Houvenaeghel G; Xerri L; Bertucci F; Birnbaum D
Breast Cancer Res; 2009; 11(2):R23. PubMed ID: 19405945
[TBL] [Abstract][Full Text] [Related]
23. Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics.
He HH; Meyer CA; Chen MW; Jordan VC; Brown M; Liu XS
Genome Res; 2012 Jun; 22(6):1015-25. PubMed ID: 22508765
[TBL] [Abstract][Full Text] [Related]
24. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
[TBL] [Abstract][Full Text] [Related]
25. Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice.
Cornelissen LM; Henneman L; Drenth AP; Schut E; de Bruijn R; Klarenbeek S; Zwart W; Jonkers J
J Mammary Gland Biol Neoplasia; 2019 Dec; 24(4):305-321. PubMed ID: 31729597
[TBL] [Abstract][Full Text] [Related]
26. Genomic transcription factor binding site selection is edited by the chromatin remodeling factor CHD4.
Saotome M; Poduval DB; Grimm SA; Nagornyuk A; Gunarathna S; Shimbo T; Wade PA; Takaku M
Nucleic Acids Res; 2024 Apr; 52(7):3607-3622. PubMed ID: 38281186
[TBL] [Abstract][Full Text] [Related]
27. FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer.
Arruabarrena-Aristorena A; Maag JLV; Kittane S; Cai Y; Karthaus WR; Ladewig E; Park J; Kannan S; Ferrando L; Cocco E; Ho SY; Tan DS; Sallaku M; Wu F; Acevedo B; Selenica P; Ross DS; Witkin M; Sawyers CL; Reis-Filho JS; Verma CS; Jauch R; Koche R; Baselga J; Razavi P; Toska E; Scaltriti M
Cancer Cell; 2020 Oct; 38(4):534-550.e9. PubMed ID: 32888433
[TBL] [Abstract][Full Text] [Related]
28. Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells.
Holmes KA; Hurtado A; Brown GD; Launchbury R; Ross-Innes CS; Hadfield J; Odom DT; Carroll JS
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2748-53. PubMed ID: 21536917
[TBL] [Abstract][Full Text] [Related]
29. Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop.
Marconett CN; Sundar SN; Poindexter KM; Stueve TR; Bjeldanes LF; Firestone GL
Mol Biol Cell; 2010 Apr; 21(7):1166-77. PubMed ID: 20130088
[TBL] [Abstract][Full Text] [Related]
30. Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha.
Frietze S; O'Geen H; Littlepage LE; Simion C; Sweeney CA; Farnham PJ; Krig SR
BMC Genomics; 2014 Jun; 15(1):520. PubMed ID: 24962896
[TBL] [Abstract][Full Text] [Related]
31. Genetic variations of DNA bindings of FOXA1 and co-factors in breast cancer susceptibility.
Wen W; Chen Z; Bao J; Long Q; Shu XO; Zheng W; Guo X
Nat Commun; 2021 Sep; 12(1):5318. PubMed ID: 34518541
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
[TBL] [Abstract][Full Text] [Related]
33. Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer.
Eeckhoute J; Keeton EK; Lupien M; Krum SA; Carroll JS; Brown M
Cancer Res; 2007 Jul; 67(13):6477-83. PubMed ID: 17616709
[TBL] [Abstract][Full Text] [Related]
34. Transcriptome mining of non-BRCA1/A2 and BRCA1/A2 familial breast cancer.
Akbari V; Kallhor M; Akbari MT
J Cell Biochem; 2019 Jan; 120(1):575-583. PubMed ID: 30125992
[TBL] [Abstract][Full Text] [Related]
35. Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis-Regulatory Landscape Exploitable in ER+ Breast Cancer.
Craig JM; Turner TH; Harrell JC; Clevenger CV
Endocrinology; 2021 May; 162(5):. PubMed ID: 33589921
[TBL] [Abstract][Full Text] [Related]
36. FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3.
Jozwik KM; Chernukhin I; Serandour AA; Nagarajan S; Carroll JS
Cell Rep; 2016 Dec; 17(10):2715-2723. PubMed ID: 27926873
[TBL] [Abstract][Full Text] [Related]
37. Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes.
Teinturier R; Abou Ziki R; Kassem L; Luo Y; Malbeteau L; Gherardi S; Corbo L; Bertolino P; Bachelot T; Treilleux I; Zhang CX; Le Romancer M
Breast Cancer Res Treat; 2021 Dec; 190(3):389-401. PubMed ID: 34561764
[TBL] [Abstract][Full Text] [Related]
38. FOXA1 is a key determinant of estrogen receptor function and endocrine response.
Hurtado A; Holmes KA; Ross-Innes CS; Schmidt D; Carroll JS
Nat Genet; 2011 Jan; 43(1):27-33. PubMed ID: 21151129
[TBL] [Abstract][Full Text] [Related]
39. The estrogen receptor/GATA3/FOXA1 transcriptional network: lessons learned from breast cancer.
Martin EM; Orlando KA; Yokobori K; Wade PA
Curr Opin Struct Biol; 2021 Dec; 71():65-70. PubMed ID: 34225008
[TBL] [Abstract][Full Text] [Related]
40. Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3.
Frietze S; Wang R; Yao L; Tak YG; Ye Z; Gaddis M; Witt H; Farnham PJ; Jin VX
Genome Biol; 2012 Sep; 13(9):R52. PubMed ID: 22951069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]